Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,345,434
+$21,859,774 QoQ
Shares Held
2,093,459
+93.3% QoQ
Ownership
0.797%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#27
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $5,256,144,156 across 13 Drug Manufacturers - General names. OGN ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
6,830,190 | $1,295,140,626 | |
| 2 | JNJ |
Johnson & Johnson
|
4,873,739 | $1,237,783,491 | |
| 3 | LLY |
ELI LILLY & Co
|
477,197 | $572,364,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,713,343 | $477,164,575 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,275,402 | $476,828,662 | |
| 6 | ABBV |
AbbVie Inc.
|
1,566,077 | $394,087,615 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,853,184 | $360,471,266 | |
| 8 | AMGN |
Amgen Inc
|
636,542 | $230,504,586 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,345,434 | 2,093,459 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,485,660 | 1,082,748 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $8,415,522 | 1,173,713 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $13,778,460 | 1,290,118 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $12,873,451 | 1,329,902 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $19,003,347 | 1,276,249 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $16,535,700 | 1,108,291 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $17,317,948 | 905,277 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $16,239,190 | 784,502 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $12,306,931 | 654,624 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $27,405,988 | 1,900,554 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $12,864,367 | 741,035 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $15,480,517 | 743,898 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,048,236 | 894,908 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $20,084,099 | 719,087 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,484,344 | 533,519 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $10,614,037 | 314,490 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,304,703 | 37,352 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,710,536 | 89,016 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,865,902 | 148,396 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $6,148,619 | 203,193 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||